2011's most important prostate cancer discovery?
Tuesday 10 January 2012
Dr Chris Parker argues that Radium-223, a bone-seeking radioisotope, could be last year's most important development in prostate cancer research. It is the first ever isotope shown to improve overall survival in a common solid cancer.
>> http://www.oncologystat.com/viewpoints/interviews/Top_Stories_of_2011_Dr_Chris_Parker_on_Prostate_Cancer.html;jsessionid=9A53AAA6A8307FB519F455D852593FA5
European Oncology Nursing SocietyAvenue E. Mounier 83
B-1200 Brussels
Belgium
Tel: +32 (0)2 779 9923
Fax: +32 (0)2 779 9937
eons.secretariat@cancernurse.eu